89 related articles for article (PubMed ID: 27125323)
21. A morphology index based on sonographic findings in ovarian cancer.
DePriest PD; Shenson D; Fried A; Hunter JE; Andrews SJ; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1993 Oct; 51(1):7-11. PubMed ID: 8244178
[TBL] [Abstract][Full Text] [Related]
22. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
[TBL] [Abstract][Full Text] [Related]
23. Conventional and color Doppler sonography in preoperative assessment of ovarian tumors.
Tempe A; Singh S; Wadhwa L; Garg A
Int J Gynaecol Obstet; 2006 Jan; 92(1):64-8. PubMed ID: 16303129
[TBL] [Abstract][Full Text] [Related]
24. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET/CT for diagnosis of primary ovarian cancer.
Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
Nucl Med Commun; 2011 Jul; 32(7):549-53. PubMed ID: 21407140
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of plasma lysophosphatidic acid levels in the differential diagnosis of ovarian cancer.
Zhang YJ; Cao LY; Fu ZZ; Wang YJ; Wang GX; Gu T
J Cancer Res Ther; 2015; 11(2):375-80. PubMed ID: 26148603
[TBL] [Abstract][Full Text] [Related]
27. Subjective sonographic assessment for differentiation between malignant and benign adnexal masses.
Tongsong T; Wanapirak C; Sukpan K; Khunamornpong S; Pathumbal A
Asian Pac J Cancer Prev; 2007; 8(1):124-6. PubMed ID: 17477786
[TBL] [Abstract][Full Text] [Related]
28. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
[TBL] [Abstract][Full Text] [Related]
29. A new sonomorphologic scoring system (Mainz Score) for the assessment of ovarian tumors using transvaginal ultrasonography. Part I: A comparison between the scoring-system and the assessment by an experienced sonographer.
Merz E; Weber G; Bahlmann F; Kiesslich R
Ultraschall Med; 1998 Jun; 19(3):99-107. PubMed ID: 9744040
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of ultrasonography markers and CA125 usefulness in the diagnosis of ovarian cysts].
Szczublewski P; Szpurek D; Moszyński R; Szubert S; Sajdak S
Ginekol Pol; 2008 Dec; 79(12):856-61. PubMed ID: 19175043
[TBL] [Abstract][Full Text] [Related]
31. An ultrasonographic morphological index for prediction of ovarian tumor malignancy.
Szpurek D; Moszynski R; Zietkowiak W; Spaczynski M; Sajdak S
Eur J Gynaecol Oncol; 2005; 26(1):51-4. PubMed ID: 15755001
[TBL] [Abstract][Full Text] [Related]
32. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features.
Brown DL; Doubilet PM; Miller FH; Frates MC; Laing FC; DiSalvo DN; Benson CB; Lerner MH
Radiology; 1998 Jul; 208(1):103-10. PubMed ID: 9646799
[TBL] [Abstract][Full Text] [Related]
33. [Use of multilayer perception artificial neutral networks for the prediction of the probability of malignancy in adnexal tumors].
Smoleń A; Czekierdowski A; Stachowicz N; Kotarski J
Ginekol Pol; 2003 Sep; 74(9):855-62. PubMed ID: 14674136
[TBL] [Abstract][Full Text] [Related]
34. Sonographic morphological pattern in the pre-operative prediction of ovarian masses.
Benjapibal M; Sunsaneevitayakul P; Phatihattakorn C; Suphanit I; Iamurairat W
J Med Assoc Thai; 2003 Apr; 86(4):332-7. PubMed ID: 12757077
[TBL] [Abstract][Full Text] [Related]
35. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison.
Chen H; Liu Y; Shen LF; Jiang MJ; Yang ZF; Fang GP
J Ovarian Res; 2016 Nov; 9(1):81. PubMed ID: 27876070
[TBL] [Abstract][Full Text] [Related]
36. [Comparision of sonographic findings and pathological features in ovarian thecoma].
Chang Q; Hao YZ; Wu N; Zhu Q; Zhang X; Li M
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):473-5. PubMed ID: 19024527
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of predictive value of the ultrasound Doppler's scale in determination of the ovarian tumors malignancy].
Szpurek D; Moszyński R; Uchman P; Sajdak S
Ginekol Pol; 2003 Sep; 74(9):878-84. PubMed ID: 14674139
[TBL] [Abstract][Full Text] [Related]
38. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
Li HM; Qiang JW; Ma FH; Zhao SH
J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
[TBL] [Abstract][Full Text] [Related]
39. [Before surgery predictability of malignant ovarian tumors based on ADNEX model and its use in clinical practice].
Joyeux E; Miras T; Masquin I; Duglet PE; Astruc K; Douvier S
Gynecol Obstet Fertil; 2016 Oct; 44(10):557-564. PubMed ID: 27568408
[TBL] [Abstract][Full Text] [Related]
40. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests.
Daemen A; Valentin L; Fruscio R; Van Holsbeke C; Melis GB; Guerriero S; Czekierdowski A; Jurkovic D; Ombelet W; Rossi A; Vergote I; Bourne T; De Moor B; Timmerman D
Ultrasound Obstet Gynecol; 2011 Jan; 37(1):100-6. PubMed ID: 20814878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
